More on SNGX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.15 |
|
|||
| Open | $1.15 | ||||
| 52 Wk High | $4.35 | ||||
| 52 Wk Low | $0.44 | ||||
| Day High | $1.20 | ||||
| Day Low | $1.12 | ||||
| P/E | N/A | ||||
| EPS | $-0.81 | ||||
| Volume | 93,305 | ||||
- SOLIGENIX receives positive EMA opinion for SGX945 orphan drug designation
- Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
- Soligenix to Present at BIO Investment & Growth Summit
- Form SCHEDULE 13G/A SOLIGENIX, INC. Filed by: ARMISTICE CAPITAL, LLC
- Form 8-K SOLIGENIX, INC. For: Feb 12
- Soligenix provides update on late-stage rare disease pipeline
- Soligenix Details Recent Progress and Upcoming Milestones
- Form 424B5 SOLIGENIX, INC.
- Soligenix enters agreement to sell up to $3.45 million in stock
- Form 8-K SOLIGENIX, INC. For: Jan 23
Entities mentioned with SNGX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- S1 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
